Foscavir

Product manufactured by Clinigen Group Plc

Application Nr Approved Date Route Status External Links
NDA020068 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications Cmv Retinitis Foscavir Is Indicated For The Treatment Of Cmv Retinitis In Patients With Acquired Immunodeficiency Syndrome (Aids). Combination Therapy With Foscavir And Ganciclovir Is Indicated For Patients Who Have Relapsed After Monotherapy With Either Drug. Safety And Efficacy Of Foscavir Have Not Been Established For Treatment Of Other Cmv Infections (E.g., Pneumonitis, Gastroenteritis); Congenital Or Neonatal Cmv Disease; Or Nonimmunocompromised Individuals. Mucocutaneous Acyclovir Resistant Hsv Infections Foscavir Is Indicated For The Treatment Of Acyclovir-Resistant Mucocutaneous Hsv Infections In Immunocompromised Patients. Safety And Efficacy Of Foscavir Have Not Been Established For Treatment Of Other Hsv Infections (E.g., Retinitis, Encephalitis); Congenital Or Neonatal Hsv Disease; Or Hsv In Nonimmunocompromised Individuals.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Foscarnet Sodium FOSCARNET SODIUM ZINC8101109

Comments